Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial
EClinicalMedicine, Jan 2026, 91 103698 | https://doi.org/10.1016/j.eclinm.2025.103698
Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
Circulation, Originally published: 5 Mar 2023 | https://doi.org/10.1161/CIRCULATIONAHA.123.064264
Peroxisome Proliferator-Activated Receptor-{delta} Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells Through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway
Circulation, Published online before print August 18, 2008, doi: 10.1161/CIRCULATIONAHA.108.777169